|
Epidemiology
Citations 11-15 of 15 total displayed.
|
Past content
(since Aug 2001):
|
- Integrative Physiology
Gene Transfer of the Urokinase-Type Plasminogen Activator Receptor-Targeted Matrix Metalloproteinase Inhibitor TIMP-1.ATF Suppresses Neointima Formation More Efficiently Than Tissue Inhibitor of Metalloproteinase-1
- M.L.M. Lamfers, J.M. Grimbergen, M.C. Aalders, M.J. Havenga, M.R. de Vries, L.G.M. Huisman, V.W.M. van Hinsbergh, and P.H.A. Quax
Circ. Res. 2002;91:945-952; published online before print as doi:10.1161/01.RES.0000041418.51906.57
[Abstract]
[Full text]
- Reviews
Advice on Statistical Analysis for Circulation Research
- Hideo Kusuoka and Julien I.E. Hoffman
Circ. Res. 2002;91:662-671, doi:10.1161/01.RES.0000037427.73184.C1
[Abstract]
[Full text]
- Reviews
Novel Clinical Markers of Vascular Wall Inflammation
- Gavin J. Blake and Paul M. Ridker
Circ. Res. 2001;89:763-771, doi:10.1161/hh2101.099270
[Abstract]
[Full text]
- Clinical Research
Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis
- David H. McDermott, Julian P.J. Halcox, William H. Schenke, Myron A. Waclawiw, Maya N. Merrell, Neal Epstein, Arshed A. Quyyumi, and Philip M. Murphy
Circ. Res. 2001;89:401-407; published online before print as doi:10.1161/hh1701.095642
[Abstract]
[Full text]
- Articles
Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis
- David H. McDermott,*, Julian P.J. Halcox,*, William H. Schenke, Myron A. Waclawiw, Maya N. Merrell, Neal Epstein, Arshed A. Quyyumi, and Philip M. Murphy
Circ. Res. published August 16, 2001, doi:10.1161/hh1701.095642
[Abstract]
[Full text]
|
|
